Cargando…

Biosynthesis of silver nanoparticles using Pseudomonas canadensis, and its antivirulence effects against Pseudomonas tolaasii, mushroom brown blotch agent

This study reports the biosynthesis of silver nanoparticles (AgNPs) using a Pseudomonas canadensis Ma1 strain isolated from wild-growing mushrooms. Freshly prepared cells of P. canadensis Ma1 incubated at 26–28 °C with a silver nitrate solution changed to a yellowish brown color, indicating the form...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghasemi, Samira, Harighi, Behrouz, Ashengroph, Morahem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985599/ https://www.ncbi.nlm.nih.gov/pubmed/36871050 http://dx.doi.org/10.1038/s41598-023-30863-x

Ejemplares similares

Resistance Sources to Brown Blotch Disease (Pseudomonas tolaasii) in a Diverse Collection of Pleurotus Mushroom Strains
por: Azu Okorley, Benjamin, et al.
Publicado: (2019)

Optimization of the Bacteriophage Cocktail for the Prevention of Brown Blotch Disease Caused by Pseudomonas tolaasii
por: Yun, Yeong-Bae, et al.
Publicado: (2022)

Bdellovibrio bacteriovorus HD100 guards against Pseudomonas tolaasii brown-blotch lesions on the surface of post-harvest Agaricus bisporus supermarket mushrooms
por: Saxon, Emma B, et al.
Publicado: (2014)

Pathogenic variation in isolates of Pseudomonas causing the brown blotch of cultivated mushroom, Agaricus bisporus
por: Abou-Zeid, Mohamed A.
Publicado: (2012)

Use of Taguchi methodology to enhance the yield of caffeine removal with growing cultures of Pseudomonas pseudoalcaligenes
por: Ashengroph, Morahem, et al.
Publicado: (2014)

Bioactivity of volatile organic compounds produced by Pseudomonas tolaasii
por: Lo Cantore, Pietro, et al.
Publicado: (2015)

Draft Genome Sequence of Pseudomonas fluorescens LMG 5329, a White Line-Inducing Principle-Producing Bioindicator for the Mushroom Pathogen Pseudomonas tolaasii
por: Ghequire, Maarten G. K., et al.
Publicado: (2013)

Exopolysaccharides from Pseudomonas tolaasii inhibit the growth of Pleurotus ostreatus mycelia
por: Xu, Yanyan, et al.
Publicado: (2023)

Use of Growing Cells of Pseudomonas aeruginosa for Synthesis of the Natural Vanillin via Conversion of Isoeugenol
por: Ashengroph, Morahem, et al.
Publicado: (2011)

Antivirulence activity of azithromycin in Pseudomonas aeruginosa
por: Imperi, Francesco, et al.
Publicado: (2014)

High-Throughput Approaches for the Identification of Pseudomonas aeruginosa Antivirulents
por: Kang, Donghoon, et al.
Publicado: (2021)

Biosynthesis of Quantum Dots and Their Therapeutic Applications in the Diagnosis and Treatment of Cancer and SARS-CoV-2
por: Moetasam Zorab, Musa, et al.
Publicado: (2023)

Fe(2+) Alleviated the Toxicity of ZnO Nanoparticles to Pseudomonas tolaasii Y-11 by Changing Nanoparticles Behavior in Solution
por: Yang, Yuran, et al.
Publicado: (2021)

Exogenous Fe(2+) alleviated the toxicity of CuO nanoparticles on Pseudomonas tolaasii Y-11 under different nitrogen sources
por: Yang, Yuran, et al.
Publicado: (2020)

Draft Genome Sequence of Pseudomonas gingeri Strain LMG 5327, the Causative Agent of Ginger Blotch in Agaricus bisporus
por: Bahrami, Tahereh, et al.
Publicado: (2018)

N-Aryl-3-mercaptosuccinimides as Antivirulence Agents Targeting Pseudomonas aeruginosa Elastase and Clostridium Collagenases
por: Konstantinović, Jelena, et al.
Publicado: (2020)

Six Multiplex TaqMan(TM)-qPCR Assays for Quantitative Diagnostics of Pseudomonas Species Causative of Bacterial Blotch Diseases of Mushrooms
por: Taparia, Tanvi, et al.
Publicado: (2020)

Activity and Impact on Resistance Development of Two Antivirulence Fluoropyrimidine Drugs in Pseudomonas aeruginosa
por: Imperi, Francesco, et al.
Publicado: (2019)

Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance
por: Liao, Chongbing, et al.
Publicado: (2022)

Sulfur Amino Acid Status Controls Selenium Methylation in Pseudomonas tolaasii: Identification of a Novel Metabolite from Promiscuous Enzyme Reactions
por: Liu, Ying, et al.
Publicado: (2021)

Inhibition of Tolaasin Cytotoxicity Causing Brown Blotch Disease in Cultivated Mushrooms Using Tolaasin Inhibitory Factors
por: Yun, Yeong-Bae, et al.
Publicado: (2023)

Application of Taguchi Design and Response Surface Methodology for Improving Conversion of Isoeugenol into Vanillin by Resting Cells of Psychrobacter sp. CSW4
por: Ashengroph, Morahem, et al.
Publicado: (2013)

Tea polyphenols as an antivirulence compound Disrupt Quorum-Sensing Regulated Pathogenicity of Pseudomonas aeruginosa
por: Yin, Honging, et al.
Publicado: (2015)

Anti-Biofilm and Antivirulence Activities of Metabolites from Plectosphaerella cucumerina against Pseudomonas aeruginosa
por: Zhou, Jinwei, et al.
Publicado: (2017)

NirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target
por: Fenn, Samuel, et al.
Publicado: (2021)

Corrigendum: Tea polyphenols as an antivirulence compound Disrupt Quorum-Sensing Regulated Pathogenicity of Pseudomonas aeruginosa
por: Yin, Hongping, et al.
Publicado: (2016)

Antivirulence Properties of a Low-Molecular-Weight Quaternized Chitosan Derivative against Pseudomonas aeruginosa
por: Maisetta, Giuseppantonio, et al.
Publicado: (2021)

Measurement and evaluation of the effects of pH gradients on the antimicrobial and antivirulence activities of chitosan nanoparticles in Pseudomonas aeruginosa
por: Aleanizy, Fadilah Sfouq, et al.
Publicado: (2018)

Phloroglucinol-Gold and -Zinc Oxide Nanoparticles: Antibiofilm and Antivirulence Activities towards Pseudomonas aeruginosa PAO1
por: Khan, Fazlurrahman, et al.
Publicado: (2021)

Screening of the Medicines for Malaria Venture Pandemic Response Box for Discovery of Antivirulent Drug against Pseudomonas aeruginosa
por: Macho, Markéta, et al.
Publicado: (2022)

Identification of FDA-approved antivirulence drugs targeting the Pseudomonas aeruginosa quorum sensing effector protein PqsE
por: Baldelli, Valerio, et al.
Publicado: (2020)

Combining antibiotics with antivirulence compounds can have synergistic effects and reverse selection for antibiotic resistance in Pseudomonas aeruginosa
por: Rezzoagli, Chiara, et al.
Publicado: (2020)

Antipathogenic Compounds That Are Effective at Very Low Concentrations and Have Both Antibiofilm and Antivirulence Effects against Pseudomonas aeruginosa
por: Hwang, Hyeon-Ji, et al.
Publicado: (2021)

Characterization of Pseudomonas aeruginosa Quorum Sensing Inhibitors from the Endophyte Lasiodiplodia venezuelensis and Evaluation of Their Antivirulence Effects by Metabolomics
por: Pellissier, Léonie, et al.
Publicado: (2021)

Molecular characterization of Pseudomonas from Agaricus bisporus caps reveal novel blotch pathogens in Western Europe
por: Taparia, Tanvi, et al.
Publicado: (2020)

Biosynthesis of Pseudomonas‐Derived Butenolides
por: Klapper, Martin, et al.
Publicado: (2020)

Antibiofilm Activity of Heather and Manuka Honeys and Antivirulence Potential of Some of Their Constituents on the DsbA1 Enzyme of Pseudomonas aeruginosa
por: Shirlaw, Oscar, et al.
Publicado: (2020)

Antivirulence Bispecific Monoclonal Antibody-Mediated Protection against Pseudomonas aeruginosa Ventilator-Associated Pneumonia in a Rabbit Model
por: Aguiar-Alves, Fábio, et al.
Publicado: (2022)

In vitro Activity of Antivirulence Drugs Targeting the las or pqs Quorum Sensing Against Cystic Fibrosis Pseudomonas aeruginosa Isolates
por: Collalto, Diletta, et al.
Publicado: (2022)

Bioactive and Structural Metabolites of Pseudomonas and Burkholderia Species Causal Agents of Cultivated Mushrooms Diseases
por: Andolfi, Anna, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_f1pq4c4dtr8th5u41hakkkuolp